Gland Pharma Ltd - Stock Price

As on17 Sep 2021
  • BSE : 543245
  • ISIN CODE : INE068V01023
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Gland Pharma Ltd is not traded on BSE/NSE
-1.99 %-80.35
-1.57 %-63.35

Gland Pharma Ltd Share Holdings

Description Percent of Share (%)
Mutual Funds/Uti11.09
More from Share holdings »

Share Holding Pattern (% of Shares Held)

ParticularsJun 2021Mar 2021Var%
Promoter and Promoter Group
Indian Promoters
    Individuals / Hindu Undivided Family
    Central Government/State Government(s)
    Bodies Corporate
    Financial Institutions / Banks
    Partnership Firms
    Promoter Group
    Employees Welfare Fund
    Any Others (Specify)
Foreign Promoters58.1458.250.19
    Non-Residents Individuals / Foreign Individuals
    'Bodies Corporate
Any Others (Specify)
Total of Promoter and Promoter Group58.1458.250.19
Public Shareholding
    Mutual Funds / UTI11.0910.28.73
    Financial Institutions / Banks0.020.020
    Insurance Companies0.460.460
    Foreign Institutional Investors
    Venture Capital Funds
    Foreign Venture Capital Investors
    Alternate Investment Funds0.540.563.57
    Foreign Portfolio investors10.4411.8712.05
    Provident funds / Pension funds
    Multilateral & Bileteral Development Financial Institution
    Any Others (Specify)
    Central Government / State Government(s)
    Foreign Financial Institutions / Banks
    Stressed Assets Stabilisation Fund
    Foreign Financial Institutions
    State Finance Corporation
    Foreign Bodies DR
    Bodies Corporate14.7914.840.34
    Individual shareholders holding nominal share capital up to Rs. 1 lakh3.112.6915.61
    Individual shareholders holding nominal share capital in excess of Rs. 1 lakh0.610.610
    NBFCs Registed with RBI0.010.010
    Employee Trusts0.120.120
    Any Others (Specify)
    Clearing Members0.20.05300
    Non Resident Indians0.20.1717.65
    Directors & their Relatives & Friends
    Foreign Collaborators
    Foreign Mutual Fund
    Hindu Undivided Families0.080.0714.29
    Foreign Corporate Bodies
    Shares in transit
    Market Maker
    Escrow Account
    Any Other0.1
Total Public Shareholding41.8641.750.26
Total of Promoter and Public Shareholding1001000
    Shares held by Custodians and against which Depository Receipts have been issued
    American Depository Receipts
Grand Total1001000


Scheme Holding(%)  
Nippon India Pharma Fund(G)4.35
SBI Focused Equity Fund-Reg(G)4.03
Motilal Oswal Flexi Cap Fund-Reg(G)3.40
SBI Equity Hybrid Fund-Reg(D)1.77
Mirae Asset Focused Fund-Reg(G)1.62
Canara Rob Emerg Equities Fund-Reg(G)1.60
SBI Magnum Global Fund-Reg(D)1.43
Franklin India Prima Fund(G)1.30
Aditya Birla SL Equity Hybrid '95 Fund(G)1.15
Kotak Equity Opp Fund(G)1.12
Axis Flexi Cap Fund-Reg(G)1.05
Invesco India Growth Opp Fund(G)1.04
Aditya Birla SL Equity Advantage Fund(D)1.03
Canara Rob Equity Hybrid Fund-Reg(G)0.97
Axis Long Term Equity Fund-Reg(G)0.91
Kotak Balanced Advantage Fund-Reg(G)0.74
L&T Hybrid Equity Fund-Reg(G)0.70
ICICI Pru Multicap Fund(G)0.57
Axis Focused 25 Fund-Reg(G)0.48
Axis Bluechip Fund-Reg(G)0.47
Axis Midcap Fund-Reg(G)0.42

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 3973.45. Its current market capitalisation stands at Rs 65258.82 Cr. In the latest quarter, company has reported Gross Sales of Rs. 34628.76 Cr and Total Income of Rs.35976.52 Cr. The company's management includes Allen Zhang, Udo Jahannes Vetter, Yifang Wu, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Naina Lal Kidwai, Xiaohui Guan, Dongming Li, Qiyu Chen, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

Latest News